Brokerages Set Addus HomeCare Corporation (NASDAQ:ADUS) Price Target at $136.90

Addus HomeCare Corporation (NASDAQ:ADUSGet Free Report) has received a consensus recommendation of “Moderate Buy” from the twelve research firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, two have given a hold rating, eight have given a buy rating and one has issued a strong buy rating on the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $136.90.

A number of equities analysts have commented on ADUS shares. TD Cowen increased their target price on Addus HomeCare from $139.00 to $140.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. Barclays increased their price objective on Addus HomeCare from $111.00 to $117.00 and gave the company an “underweight” rating in a research note on Tuesday, November 4th. BMO Capital Markets began coverage on shares of Addus HomeCare in a report on Thursday, November 13th. They set a “market perform” rating and a $120.00 target price for the company. Truist Financial set a $135.00 target price on shares of Addus HomeCare and gave the company a “buy” rating in a research report on Wednesday, January 7th. Finally, Royal Bank Of Canada boosted their price target on shares of Addus HomeCare from $134.00 to $139.00 and gave the stock an “outperform” rating in a research report on Friday, November 7th.

Get Our Latest Stock Report on Addus HomeCare

Addus HomeCare Price Performance

Addus HomeCare stock traded down $2.30 during trading on Friday, reaching $107.50. The company had a trading volume of 248,820 shares, compared to its average volume of 147,228. The firm has a market capitalization of $1.99 billion, a PE ratio of 23.02, a price-to-earnings-growth ratio of 1.29 and a beta of 0.92. The firm’s 50-day simple moving average is $112.52 and its 200 day simple moving average is $113.25. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.66 and a current ratio of 1.66. Addus HomeCare has a 1-year low of $88.96 and a 1-year high of $136.72.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last posted its quarterly earnings data on Monday, November 3rd. The company reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.53 by $0.03. Addus HomeCare had a net margin of 6.36% and a return on equity of 9.53%. The business had revenue of $362.30 million for the quarter, compared to the consensus estimate of $354.48 million. During the same period last year, the firm posted $1.30 earnings per share. The company’s revenue was up 25.0% compared to the same quarter last year. As a group, equities research analysts anticipate that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Addus HomeCare news, EVP Darby Anderson sold 20,000 shares of the company’s stock in a transaction on Wednesday, November 19th. The stock was sold at an average price of $109.00, for a total value of $2,180,000.00. Following the completion of the sale, the executive vice president directly owned 44,144 shares in the company, valued at $4,811,696. This represents a 31.18% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold a total of 20,316 shares of company stock worth $2,215,998 in the last quarter. Company insiders own 4.50% of the company’s stock.

Hedge Funds Weigh In On Addus HomeCare

Several institutional investors and hedge funds have recently bought and sold shares of ADUS. Hohimer Wealth Management LLC increased its holdings in shares of Addus HomeCare by 3.4% during the 3rd quarter. Hohimer Wealth Management LLC now owns 2,709 shares of the company’s stock worth $320,000 after buying an additional 88 shares during the last quarter. Ameritas Investment Partners Inc. increased its stake in Addus HomeCare by 5.0% during the second quarter. Ameritas Investment Partners Inc. now owns 1,854 shares of the company’s stock worth $214,000 after acquiring an additional 89 shares during the last quarter. Amalgamated Bank raised its position in Addus HomeCare by 1.8% in the third quarter. Amalgamated Bank now owns 5,240 shares of the company’s stock valued at $618,000 after purchasing an additional 93 shares during the period. First Hawaiian Bank lifted its stake in shares of Addus HomeCare by 2.0% in the 1st quarter. First Hawaiian Bank now owns 4,898 shares of the company’s stock valued at $484,000 after purchasing an additional 95 shares during the last quarter. Finally, Maryland State Retirement & Pension System grew its holdings in shares of Addus HomeCare by 1.9% during the 2nd quarter. Maryland State Retirement & Pension System now owns 5,335 shares of the company’s stock worth $615,000 after purchasing an additional 101 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.

About Addus HomeCare

(Get Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Featured Articles

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.